Username:

Password:
GO
Forgotten your login details? Click here

THE QUEST FOR NEW MEDICINES TO SLOW THE PROGRESSION OF DISABILITY IN NEURODEGENERATIVE DISORDERS
Monday 18 November 2024
AstraZeneca - The Discovery Centre (DISC), 1 Francis Crick Ave, Cambridge Biomedical Campus, CB2 0AA, UK

Joint meeting with The British Neuroscience Association  

OVERVIEW

Neurodegenerative disorders affect the structure and function of the central nervous system, leading to the progressive loss of cognitive, motor, and sensory abilities. They include Alzheimer's disease, Parkinsonís disease, motor neuron disease, multiple sclerosis, Huntingtonís disease, stroke and traumatic brain injury. Neurodegenerative disorders pose a major challenge for public health as they affect millions of people worldwide. Moreover, they are associated with a high burden of disability, morbidity, mortality, and socioeconomic costs. And yet, there are no medicines to slow the progression of disability.

This symposium will review the progress made in the quest to discover new medicines to slow the progression of disability associated with neurodegenerative disorders.

OVERVIEW
PROGRAMME